Background: Vascular endothelial growth factor D (VEGFD), a member of the VEGF family, is implicated in angiogenesis and lymphangiogenesis, and is deemed to be expressed at a low level in cancers. S-nitrosylation, a NO (nitric oxide)-mediated post-translational modification has a critical role in angiogenesis. Here, we attempt to dissect the role and underlying mechanism of S-nitrosylation-mediated VEGFD suppression in lung adenocarcinoma (LUAD).

Methods: Messenger RNA and protein expression of VEGFD in LUAD were analyzed by TCGA and CPTAC database, respectively, and Assistant for Clinical Bioinformatics was performed for complex analysis. Mouse models with urethane (Ure)-induced LUAD or LUAD xenograft were established to investigate the role of S-nitrosylation in VEGFD expression and of VEGFD mutants in the oncogenesis of LUAD. Molecular, cellular, and biochemical approaches were applied to explore the underlying mechanism of S-nitrosylation-mediated VEGFD suppression. Tube formation and wound healing assays were used to examine the role of VEGFD on the angiogenesis and migration of LUAD cells, and the molecular modeling was applied to predict the protein stability of VEGFD mutant.

Results: VEGFD mRNA and protein levels were decreased to a different extent in multiple primary malignancies, especially in LUAD. Low VEGFD protein expression was closely related to the oncogenesis of LUAD and resultant from excessive NO-induced VEGFD S-nitrosylation at Cys277. Moreover, inhibition of S-nitrosoglutathione reductase consistently decreased the VEGFD denitrosylation at Cys277 and consequently promoted angiogenesis of LUAD. Finally, the VEGFD mutant decreased the secretion of mature VEGFD by attenuating the PC7-dependent proteolysis and VEGFD mutant thus reversed the effect of VEGFD on angiogenesis of LUAD.

Conclusion: Low-expression of VEGFD positively correlates with LUAD development. Aberrant S-nitrosylation of VEGFD negates itself to induce the tumorigenesis of LUAD, whereas normal S-nitrosylation of VEGFD is indispensable for its secretion and repression of angiogenesis of LUAD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358865PMC
http://dx.doi.org/10.1186/s13046-022-02453-8DOI Listing

Publication Analysis

Top Keywords

vegfd
19
s-nitrosylation vegfd
12
luad
11
vegfd expression
8
lung adenocarcinoma
8
underlying mechanism
8
mechanism s-nitrosylation-mediated
8
s-nitrosylation-mediated vegfd
8
vegfd suppression
8
protein expression
8

Similar Publications

Article Synopsis
  • Successful engineering of vascularized tissues requires incorporating blood capillaries and connecting them to host vessels, which involves arranging endothelial cells to create functional networks.
  • The study compares induced pluripotent stem cell-derived endothelial cells (iPSC-ECs) and primary endothelial cells, finding they perform similarly in forming a capillary-like structure in lab tests.
  • Results indicate that activating certain genes can enhance the tubulogenic activity of iPSC-ECs, supporting their potential use in developing vascularized tissues for therapies.
View Article and Find Full Text PDF

The development for emerging biomarkers of lymphangioleiomyomatosis.

Orphanet J Rare Dis

November 2024

Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.

Lymphangioleiomyomatosis (LAM) is a rare, slowly progressing, low-grade metastatic tumor primarily affecting women. Currently, vascular endothelial growth factor-D (VEGF-D) is the only validated diagnostic biomarker, enabling diagnosis of LAM without the need for lung biopsy in appropriate clinical settings. However, VEGF-D concentrations are normal in about 30% of patients, rendering it insufficient for diagnosing all cases of LAM.

View Article and Find Full Text PDF

Molecular Characterization and Interaction between Human VEGF-D and VEGFR-3.

J Microbiol Biotechnol

November 2024

Department of Molecular Biology, College of Natural Sciences, Pusan National University, Busan 46241, Republic of Korea.

Angiogenesis and lymphangiogenesis are some of the routes that cause metastasis. Vascular Endothelial Growth Factors (VEGFs) stimulate angiogenesis and lymphangiogenesis through VEGF receptors. Especially, VEGF-D and its receptor, VEGFR-3, play a pivotal role in regulating cellular processes such as survival, proliferation, and migration, thereby influencing lymphangiogenesis.

View Article and Find Full Text PDF

Aim: Atezolizumab/bevacizumab is a first-line therapy for unresectable hepatocellular carcinoma (HCC). Among several adverse events, grade ≥2 proteinuria is considered a significant adverse event that may cause bevacizumab interruption. Studies have shown that proteinuria might predict improved prognosis, although data are scarce and the association remains controversial, and the mechanisms and predictive factors remain unclear.

View Article and Find Full Text PDF

Tea is one of the most widely consumed beverages in the world. However, the association between tea and risk of pancreatic adenocarcinoma remains controversial. This study aimed to investigate the causal relationship between tea consumption and risk of pancreatic adenocarcinoma and to explore their mediating effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!